"World's First Breast Cancer Vaccine Recipient Shares Life-Changing Experience"



Jennifer Davis, a 46-year-old nurse and mother from Ohio, was the first woman in the U.S. to get a new vaccine that might prevent a tough type of breast cancer from coming back. She was part of a study by Cleveland Clinic. Jennifer had a type of cancer called triple-negative breast cancer a few years ago. This cancer can come back even after it goes away for a while. The vaccine she got is hoped to stop this from happening.

In 2021, Jennifer Davis took a new vaccine that might stop a certain cancer from returning. She found a lump in her breast in 2018. At first, it wasn't cancer. But later that year, tests said it was a type called triple-negative. Jennifer had treatment right away, which included removing both her breasts and getting radiation. Her cancer hadn't spread. She's been without cancer for five years. Now, scientists want to see if the vaccine can stop other women from getting this cancer.

Jennifer Davis has been cancer-free for five years and feels that her life has changed. She no longer worries daily about the cancer coming back. Tests also show no bad side effects or return of her cancer.

Dr. Megan Kruse from Cleveland Clinic talked about Jennifer being the first patient in their study to get this new vaccine.

Triple-negative breast cancer is unique. It doesn't have certain proteins that many other breast cancers have, making it harder to treat. Jennifer's type of cancer also lacks enough of a key factor (HER2) that helps control breast cell health.